Clinical value of 18F-FDG-PET-CT in the preoperative staging of peritoneal carcinomatosis from colorectal origin

Acta Chirurgica Belgica

Volumn 114, Issue 6, 2014, Pages 370-375

  De Vos, N ^a   Goethals, I ^a   Ceelen, W ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ABDOMINAL SURGERY; ADULT; AGED; CANCER STAGING; COLORECTAL TUMOR; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PERITONEUM TUMOR; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PREOPERATIVE CARE; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY; SECONDARY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84952065266     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2014.11681046     Document Type: Article

References (17)

1. HERSZENYI L., TULASSAY Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci, 14:249-258.
2. PEETERS M., PRICE T. Biologic therapies in the metastatic colorectal cancer treatment continuum - Applying current evidence to clinical practice. Cancer Treatment Reviews, 2012, 38:397-406.
3. SODEK K. L., MURPHY K. J., BROWN T. J., RINGUETTE M. J. Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev, 2012, 31:397-414.
4. SUGARBAKER P. H., RYAN D. P. Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncology, 2012, 13:E362-E369.
5. VERWAAL V. J., VAN RUTH S., DE BREE E., VAN SLOOTEN G. W., VAN TINTEREN H., BOOT H., ZOETMULDER F. A. N. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Journal of Clinical Oncology, 2003, 21:3737-3743.
6. CEELEN W. P. Current management of peritoneal carcinomatosis from colorectal cancer. Minerva Chir, 2013, 68:77-86.
7. GONZALEZ-MORENO S., GONZALEZ-BAYON L., ORTEGA-PEREZ G., GONZALEZ-HERNANDO C. Imaging of Peritoneal Carcinomatosis. Cancer Journal, 2009, 15:184-189.
8. LIN M., WONG K. R., NGW. L., SHON I. H., MORGAN M. Positron emission tomography and colorectal cancer. Critical Reviews in Oncology Hematology, 2011, 77:31-48.
9. CEELEN W., DE SOMER F., VAN NIEUWENHOVE Y., VANDE PUTTE D., PATTYN P. Effect of perfusion temperature on glucose and electrolyte transport during hyperthermic intraperitoneal chemoperfusion (HIPEC) with oxaliplatin. European Journal of Surgical Oncology, 2012.
10. CEELEN W. P., PEETERS M., HOUTMEYERS P., BREUSEGEM C., DE SOMER F., PATTYN P. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis. Annals of Surgical Oncology, 2008, 15:535-541.
11. SOUSSAN M., DES GUETZ G., BARRAU V., AFLALO-HAZAN V., POP G., MEHANNA Z., RUST E., APARICIO T., DOUARD R., BENAMOUZIG R., WIND P., EDER V. Comparison of FDG-18F-FDG-PET-CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy. Eur Radiol, 2012, 22:1479-1487.
12. PFANNENBERG C., KONIGSRAINER I., ASCHOFF P., OKSUEZ M. O., ZIEKER D., BECKERT S., SYMONS S., NIESELT K., GLATZLE J., WEYHERN C. V., BRUCHER B. L., CLAUSSEN C. D., KONIGSRAINER A. (18) F-FDG-18F-FDG-PET-CT to Select Patients with Peritoneal Carcinomatosis for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology, 2009, 16:1295-1303.
13. BERGER K. L., NICHOLSON S. A., DEHDASHTI F., SIEGEL B. A. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol, 2000, 174:1005-1008.
14. DROMAIN C., LEBOULLEUX S., AUPERIN A., GOERE D., MALKA D., LUMBROSO J., SCHUMBERGER M., SIGAL R., ELIAS D. Staging of peritoneal carcinomatosis: enhanced CT vs. 18F-FDG-PET-CT. Abdom Imaging, 2008, 33:87-93.
15. BERTHELOT C., MOREL O., GIRAULT S., VERRIELE V., POIRIER A. L., MOROCH J., BOUCHER Y., LEJEUNE J. J., LORIMIER G. Use of FDG-18F-FDG-PET-CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy. Nucl Med Commun, 2011, 32:23-29.
16. KLUMPP B. D., SCHWENZER N., ASCHOFF P., MILLER S., KRAMER U., CLAUSSEN C. D., BRUECHER B., KOENIGSRAINER A., PFANNENBERG C. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG 18F-FDG-PET-CT and MRI. Abdom Imaging, 2013, 38:64-71.
17. JACQUET P., JELINEK J. S., STEVES M. A., SUGARBAKER P. H. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer, 1993, 72:1631-1636.